Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 77 recruiting now early-phase tilt #72 of 28,707 conditions

PTSD: early-phase trial registry

77 of 155 indexed PTSD trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #72 of 28,707 conditions by registered trial count.

155 US clinical trials · 77 currently recruiting · #72 of 28,707 conditions by registered trial count

PTSD: 155 US clinical trials tracked, 77 recruiting.

PTSD is the subject of 155 registered US clinical trials on ClinicalTrials.gov, 77 of them currently open to new participants. 10 are in Phase 3-4 (later-stage) and 29 in Phase 1-2 (earlier-stage). The most active sponsor is VA Office of Research and Development, running 28 of these trials.

Enrollment posture brief

Registry condition ptsd

OPEN 77 | RECR 50% | LATE 10 | EARLY 29 | RANK #72 | SPON 28

Nearest open-share peer: Alzheimer Disease (50% recruiting · 312 trials)

PTSD (this)50%Obstructive Sleep Apnea42%Stress41.8%Insomnia40.8%Influenza17.2%
Open-enrollment share among volume-matched conditions near PTSD

PTSD lists 77 open slots (50% of 155 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for PTSD on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. PTSD is recruiting above its size-band peers.

    77 of 155 indexed trials (49.7%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates PTSD research.

    VA Office of Research and Development accounts for 28 of 155 trials (18.1%). 88 distinct sponsors appear on at least one study for this condition label.

  3. Typical PTSD enrolment sits around 75 participants.

    Median target enrolment is 75 among the 155 trials that report a genuine target (sentinel values excluded). 89 of those (57.4%) plan for fewer than 100 participants.

  4. PTSD research is mostly interventional.

    143 interventional and 12 observational studies make up this index (92.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 17Phase 222Phase 35Phase 45

Phase Distribution

PhaseTrial count
Phase 1 7
Phase 2 22
Phase 3 5
Phase 4 5

Named interventions

Most-linked intervention names on PTSD records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Cognitive Processing Therapy Behavioral
11 trials
Placebo Drug
9 trials
Treatment as Usual Behavioral
3 trials
Ketamine Drug
3 trials
Placebo Other
3 trials
Low Intensity Exercise Behavioral
2 trials
Cognitive Processing Therapy (CPT) Behavioral
2 trials
Exposure Therapy Behavioral
2 trials

US sites by state

Facility locations filed on PTSD trials. A trial with sites in several states counts in each.

California 26 trials
Texas 20 trials
New York 19 trials
Massachusetts 15 trials
South Carolina 14 trials
Florida 13 trials
Wisconsin 10 trials
Washington 10 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this PTSD page

155 registered trials, 77 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This PTSD condition card totals 155 registered trials; most-linked intervention Cognitive Processing Therapy; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.